StreetInsider.com News Articles

Health Catalyst names Simeon Kohl as CEO, replacing Ben Albert

Tue, 08 Sep 2026 08:00:33 -0400

Health Catalyst, Inc. (Nasdaq: HCAT) announced the appointment of Simeon Kohl as Chief Executive Officer, President, and member of its Board of Directors, effective September 14, 2026.

Kohl most recently served as CEO of Performant Healthcare, a public healthcare company whose sale to Machinify closed for approximately $670 million. He has more than 20 years of experience in healthcare operations, growth, and public-company leadership.

Outgoing CEO and President Ben Albert will transition to the role of Chief Business Officer and will step down from the Board of Directors effective September 13, 2026. During his tenure, Albert led the divestiture of Vitalware, which

Health Catalyst Appoints Simeon Kohl as Chief Executive Officer and President

Tue, 08 Sep 2026 08:00:00 -0400

Kohl brings public-company leadership and a record of successful transformation; Ben Albert to continue as Chief Business Officer

SALT LAKE CITY, Sept. 08, 2026 (GLOBE NEWSWIRE) -- Health Catalyst, Inc. (“Health Catalyst” or the “Company,” Nasdaq: HCAT), a healthcare intelligence company designed to accelerate measurable improvement for health systems, today announced that Simeon Kohl has been appointed Chief Executive Officer (CEO) and President and a member of the Company’s Board of Directors, effective September 14, 2026.

Simeon Kohl most recently served as Chief Executive Officer of Performant Healthcare, a public healthcare company he led through a period of

Health Catalyst Appoints Simeon Kohl as Chief Executive Officer and President

Tue, 08 Sep 2026 08:00:00 -0400

Kohl brings public-company leadership and a record of successful transformation; Ben Albert to continue as Chief Business Officer

Simeon Kohl most recently served as Chief Executive Officer of Performant Healthcare, a public healthcare company he led through a period of

Health Catalyst to Participate in Upcoming Investor Conference

Mon, 31 Aug 2026 16:05:00 -0400

SALT LAKE CITY, Aug. 31, 2026 (GLOBE NEWSWIRE) -- Health Catalyst, Inc. ("Health Catalyst", Nasdaq: HCAT), a healthcare intelligence company designed to accelerate measurable improvement for health systems, today announced that members of senior management will participate in the 2026 Wells Fargo Healthcare Conference, taking place in Boston, on Wednesday, September 9, 2026 and Thursday, September 10, 2026.

About Health Catalyst

Health Catalyst, Inc. (Nasdaq: HCAT) is a healthcare intelligence company designed to accelerate measurable improvement for health systems across cost, clinical, and consumer performance. Backed by deep domain expertise, proprietary AI-driven technology, and $2.8 billion

Health Catalyst to Participate in Upcoming Investor Conference

Mon, 31 Aug 2026 16:05:00 -0400

About Health Catalyst

Canaccord Downgrades Health Catalyst Inc. (HCAT) to Hold

Thu, 20 Aug 2026 16:11:02 -0400

Canaccord analyst Richard Close downgraded Health Catalyst Inc. (NASDAQ: HCAT) from Buy to Hold with a price target of $1.80.

For an analyst ratings summary and ratings history on Health Catalyst Inc. click here. For more ratings news on Health Catalyst Inc. click here.

Shares of Health Catalyst Inc. closed at $1.69 yesterday.

Form SCHEDULE 13G/A Health Catalyst, Inc. Filed by: Stoney Lonesome HF LP

Fri, 14 Aug 2026 16:31:00 -0400

si-local-file:///var/storage/secattach/20260814/26931421.html

Form SCHEDULE 13G/A Health Catalyst, Inc. Filed by: Stoney Lonesome HF LP

Fri, 14 Aug 2026 16:31:00 -0400

si-local-file:///var/storage/secattach/20260814/26931421.html

Health Catalyst Inc. (HCAT) PT Lowered to $1.50 at Wells Fargo

Thu, 13 Aug 2026 08:42:07 -0400

Wells Fargo analyst Stan Berenshteyn lowered the price target on Health Catalyst Inc. (NASDAQ: HCAT) to $1.50 (from $1.75) while maintaining a Equal Weight rating.

Health Catalyst (HCAT) Misses Q2 EPS by 58c

Thu, 06 Aug 2026 18:29:12 -0400

Health Catalyst (NASDAQ: HCAT) reported Q2 EPS of ($0.55), $0.58 worse than the analyst estimate of $0.03. Revenue for the quarter came in at $70.4 million versus the consensus estimate of $68.97 million.

For earnings history and earnings-related data on Health Catalyst (HCAT) click here.

Form 10-Q Health Catalyst, Inc. For: Jun 30

Thu, 06 Aug 2026 16:59:00 -0400

si-local-file:///var/storage/secattach/20260806/26885256.html

Form 10-Q Health Catalyst, Inc. For: Jun 30

Thu, 06 Aug 2026 16:59:00 -0400

si-local-file:///var/storage/secattach/20260806/26885256.html

Form 8-K Health Catalyst, Inc. For: Jul 31

Thu, 06 Aug 2026 16:10:00 -0400

si-local-file:///var/storage/secattach/20260806/26883919.html

Form 8-K Health Catalyst, Inc. For: Jul 31

Thu, 06 Aug 2026 16:10:00 -0400

si-local-file:///var/storage/secattach/20260806/26883919.html

Health Catalyst sells Vitalware for $147M, retires credit facility debt

Thu, 06 Aug 2026 16:03:13 -0400

Health Catalyst, Inc. (Nasdaq: HCAT) closed the sale of its Vitalware business unit to Med-Metrix, LLC on July 31, 2026, for $147 million in total cash consideration, subject to customary adjustments, according to a press release.

Health Catalyst used the net proceeds from the transaction, combined with cash on hand, to fully repay and terminate all obligations under its credit facility. The company said this eliminates approximately $19 million in annual interest expense on a GAAP basis, based on annualizing the first half of 2026.

Vitalware is a suite of mid-revenue cycle solutions that helps hospitals and health systems with coding compliance,

Health Catalyst sells Vitalware for $147M, retires credit facility debt

Thu, 06 Aug 2026 16:03:13 -0400

Vitalware is a suite of mid-revenue cycle solutions that helps hospitals and health systems with coding compliance,

Health Catalyst Reports Second Quarter 2026 Results